Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

SELL
$3.4 - $4.24 $68,000 - $84,800
-20,000 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$3.76 - $5.14 $75,200 - $102,800
20,000 New
20,000 $85,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Cannon Global Investment Management, LLC Portfolio

Follow Cannon Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannon Global Investment Management, LLC with notifications on news.